Keywords: AKI; acute kidney injury; NT-proBNP; N-terminal pro-B-type natriuretic peptide; sCr; serum creatinine; eGFR; glomerular filtration rate was estimated; RRT; renal replacement therapy; N-terminal pro-B-type natriuretic peptide; Acute kidney injury; Lung can
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Biotin; Interference; Sandwich immunoassay; Competitive immunoassay; HCG; human chorionic gonadotropin; PCT; procalcitonin; PTH; parathyroid hormone; hs-TnT; troponin; LH; luteinizing hormone; NT-proBNP; N-terminal pro-B-type natriuretic peptide; TSH; thy
Keywords: LV; left ventricle; GLS; global longitudinal strain; CMR; cardiac magnetic resonance; LVEF; left ventricular ejection fraction; ECOG; Eastern Cooperative Oncology Group; HER2; human epidermal growth factor receptor 2; NYHA; New York Heart Association; Nt-
Keywords: Atrial fibrillation; TGF-β1; Matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio; NT-proBNP; Left atrial diameter; Atrial remodeling; AF; atrial fibrillation; ECM; extracellular matrix; IL-6; interleukin-6; IQR; interquartile range;
Keywords: Iron deficiency; Pulmonary hypertension; Connective tissue disease; High sensitive C reactive protein; PH; Pulmonary hypertension; PVR; pulmonary vascular resistance; PAH; pulmonary arterial hypertension; CTEPH; chronic thromboembolic pulmonary hypertensi
Keywords: MI; myocardial infarction; LV; left ventricle; EF; ejection fraction; HF; heart failure; STEMI; ST-segment-elevation myocardial infarction; NSTEMI; non-ST-segment-elevation myocardial infarction; PCI; percutaneous coronary intervention; BMI; body mass
Keywords: 1TC; 1st trimester control group; 1T non-PE; 1st trimester of non-preeclamptic women; 1T-PE; 1st trimester of preeclamptic women; 2TC; 2nd trimester control group; 3TC; 3rd trimester control group; Ca; calcium; E-PE; early-onset preeclampsia; GH; gestatio
Keywords: Kawasaki disease; Atrial; Deformation; Diastolic; aKD; Children in the acute phase of Kawasaki disease; CAL; Coronary artery lesion; CI; Confidence interval; EF; Ejection fraction; ε; Strain; ICC; Intraclass correlation coefficient; IVIG; Intravenous imm
Keywords: ANC; absolute neutrophil count; CK-MB; creatine kinase MB; CRP; C-reactive protein; ECG; electrocardiography; ESR; erythrocyte sedimentation rate; FDA; US Food and Drug Administration; NT-proBNP; N-terminal pro-brain natriuretic peptide; REMS; Risk Evalua
Keywords: Biotin; Immunoassay interference; Streptavidin; Prevalence; FDA; Food and Drug Administration; ED; Emergency Department; IRB; Institutional Review Board; PST; plasma separator tube; LC-MS/MS; liquid chromatography tandem-mass spectrometry; EMR; Electronic
Keywords: biomarkers; catheterizations; pulmonary arterial hypertension; 6MWD; 6-min walk distance; BNP; brain natriuretic peptide; CHD; congenital heart disease; CTD; connective tissue disease; ESC/ERS; European Society of Cardiology/European Respiratory Society;
Keywords: HDP; hypertensive disorders of pregnancy; GH; gestational hypertension; PE; preeclampsia; AT1; type-1 angiotensin II receptor; HF; heart failure; NP; natriuretic peptide; BNP; B-type natriuretic peptide; NT-proBNP; N-terminal pro-B-type natriuretic peptid
Keywords: Light-chain (AL) amyloidosis; Cardiac amyloidosis; Heart failure; NT-proBNP; Free light-chains; Dexamethasone; Treatment; Mortality mortality;
Keywords: Atrial fibrillation; Adiponectin; NT-proBNP; Ablation;
Keywords: AKT; Protein kinase B; BNP; brain natriuretic peptide; CRP; C-reactive protein; eGFR; estimated glomerular filtration rate; HF; heart failure; HFmrEF; heart failure with mid-range ejection fraction; HFpEF; heart failure with preserved ejection fraction; H
Keywords: Galectin-3; Systemic sclerosis; All-cause mortality; Cardiovascular mortality; NT-proBNP;
Keywords: BM-MNCs; bone marrow-derived mononuclear cells; CK-MB; creatine kinase-MB; CMR; cardiac magnetic resonance; EF; ejection fraction; HLHS; hypoplastic left heart syndrome; NT-proBNP; N-terminal pro-B-type natriuretic peptide; RV; right ventricle;
Keywords: high-sensitivity cardiac troponin T; NH2-terminal pro-brain natriuretic peptide; swimming; Tanner stage; sex; cTnI; Cardiac troponin I; cTnT; Cardiac troponin T; HR; Heart rate; hs-cTnT; High-sensitivity cTnT; NT-proBNP; NH2-terminal probrain natriuretic
Keywords: Renal dysfunction; NT-proBNP; Blood urea nitrogen to creatinine ratio; Heart failure with preserved ejection fraction; Heart failure with mid-range ejection fraction;
Keywords: heart failure; myocardial injury; obesity paradox; outcomes; BMI; body mass index; CHD; coronary heart disease; hs-cTnT; cardiac troponin TÂ measured using high-sensitivity assay; CV; cardiovascular; HF; heart failure; NT-proBNP; N-terminal pro-B-type nat
Keywords: Adult congenital heart disease; Heart transplantation; Heart-lung transplantation; Pulmonary vascular resistance; Cardiopathies congénitales de l'adulte; Transplantation cardiaque; Transplantation cardiopulmonaire; Résistances vasculaires pulmonaire
Keywords: Peripheral vascular disease; Lower limb revascularisation; Cardiopulmonary Exercise test; Bike test; Arm crank; Anaerobic threshold; Peak VO2; NT-proBNP;
Keywords: CCS; clinical congestion score; CXR; Chest X-ray; EACVI; European Association of Cardiovascular Imaging; E/eâ²; ratio of early diastolic mitral inflow velocity to early diastolic velocity of the mitral annulus; EVLW; extravascular lung water; HF; heart f
Keywords: thoracic surgery; reperfusion injury; postoperative care; adenosine; biomarkers; intensive care units; AP; Alkaline phosphatase; CICU; Cardiac intensive care unit; CPB; Cardiopulmonary bypass; iFABP; Intestinal fatty acid binding protein; LOS; Length of s
Keywords: heart failure; heart rate variability; risk prediction; CAD; coronary artery disease; CHF; congestive heart failure; ECG; electrocardiogram; GND; Greenwood-Nam-D'Agostino; HRT; heart rate turbulence; HRV; heart rate variability; MI; myocardial infarction;
Keywords: MitraClip; mitral regurgitation; mitral stenosis; transcatheter mitral valve repair; CI; confidence interval; HR; hazard ratio; MC; MitraClip; MR; mitral regurgitation; MVOA; mitral valve opening area; MVPG; mitral valve pressure gradient; MS; mitral ste
Keywords: congestive heart failure; metabolomic profiling; prognosis; risk stratification; 6MWD; 6-min walking distance; AA; amino acid; AC; acylcarnitine; EF; ejection fraction; GC; gas chromatography; HF; heart failure; HFrEF; heart failure with reduced ejection
Keywords: Connective tissue diseases; systemic lupus erythematosus; rheumatoid arthritis; systemic sclerosis; vasculitis; biomarkers; AAV; ANCA-associated vasculitides; ACA; Anti-centromere antibody; ACPA; Anti-citrullinated protein antibody; ACR; American College
Keywords: CKD; chronic kidney disease; CVD; cardiovascular disease; DM; diabetes mellitus; eGFR; estimated glomerular filtration rate; ESRD; end-stage renal disease; HR; hazard ratio; MDRD; modification of diet in renal disease formula; hsCRP; high-sensitivity C-re
Keywords: ECMO; Extracorporeal membrane oxygenation; ARDS; Acute respiratory distress syndrome; SIMV-PRVC; Synchronized intermittent mandatory ventilation-pressure regulated volume control; CXR; Chest X-ray; CRP; C-Reactive protein; TLC; Total leukocyte count; ANC;
Keywords: heart failure; quality of life; palliative care; CI; confidence interval; FACIT-Pal; Functional Assessment of Chronic Illness Therapy-Palliative Care scale; FACIT-SP; Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being scale; HAD
Keywords: pulmonary hypertension; prematurity; bronchopulmonary dysplasia; echocardiography; pediatric pulmonary hypertension network; cardiac catheterization; ASDs; Atrial septal defects; AVT; Acute vasodilator testing; BPD; Bronchopulmonary dysplasia; BNP; Brain
Keywords: ACC; American College of Cardiology; ACEI; Angiotensin-Converting Enzyme Inhibitor; ADHERE; Acute Decompensated Heart Failure Registry; AHA; American Heart Association; AHF; Acute Heart Failure; ARB; Angiotensin II Receptor Blocker; ASCEND-HF; Acute Study
Keywords: congenital heart disease; developmental lung disease; pulmonary vascular disease; right heart failure; risk factors; treatment algorithm; CHD; congenital heart disease; ES; Eisenmenger syndrome; HPAH; heritable pulmonary arterial hypertension; IPAH; idiop
Keywords: Atrial fibrillation; BNP; B-type natriuretic peptide; N-terminal pro B-type natriuretic peptide; NT-proBNP; proBNP; Soluble ST2; Troponin;
Keywords: ACE; angiotensin converting enzyme; CVP; central venous pressure; HF; heart failure; HFrEF; heart failure with reduced ejection fraction; LVEF; left ventricular ejection fraction; LVOT; left ventricular outflow tract; MAP; mean arterial pressure; NT-proBN
Keywords: cTnT; Cardiac troponin T; CPHPC; R-1-[6-[R-2-carboxy-pyrrolidin-1-yl]-6-oxo-hexanoyl]pyrrolidine-2-carboxylic acid; EGCG; epigallocethechin-3-gallate; FLC-diff; difference between involved and uninvolved serum free light chain; FDA; Food and Drug Administ
Keywords: AL; amyloid light-chain; AA; amyloid A; AF; familial amyloidosis; ATTRwt; transthyretin-related amyloidosis wild-type; AH; amyloid A hereditary; NT-proBNP; N-terminal proBrain natriuretic peptide; Amyloidosis; Malocclusion; Temporomandibular joint; Oral m
Keywords: Neutrophil-lymphocyte ratio; Troponin T; NT-proBNP; Percutaneous coronary intervention; Cardiac death;
Keywords: HF; Heart Failure; FMD; Flow Mediated Dilation; LVEF; Left Ventricular Ejection Fraction; BP; Blood Pressure; SBP; Systolic Blood Pressure; DBP; Diastolic Blood Pressure; COD; Cause of Death; BMI; Body Mass Index; NT-ProBNP; N-terminal pro-Brain Natriuret
Keywords: MR-proANP; mid-regional pro-atrial natriuretic peptide; HF; heart failure; LVEF; left ventricular ejection fraction; BMI; body mass index; NT-proBNP; N-terminal pro-B-type natriuretic peptide; NYHA; New York Heart Association; Heart failure; Natriuretic p
Keywords: biopsy; bortezomib; cardiac amyloidosis; light-chain amyloidosis; NT-proBNP;
Keywords: acute decompensated heart failure; obesity; prognosis; severe obesity; ACS; acute coronary syndrome; AHF; acute heart failure; BMI; body mass index; HF; heart failure; HFpEF; heart failure with preserved left ventricular ejection fraction; LV; left ventri
Keywords: Nutritional Risk Screening (NRS-2002); Nutritional condition; Nutritional status; Severity of disease; Age; Survival; BMI; body mass index; COPD; chronic obstructive pulmonary disease; EF; ejection fraction; CHF; chronic heart failure; CRP; C-reactive pro
Keywords: Type 2 diabetes mellitus; Antidiabetic drugs; Cardiovascular safety; Cardiovascular disease; Cardiovascular outcome trials; A1C; glycated A1c hemoglobin; ACEi; angiotensin converting enzyme inhibitor; ACS; acute coronary syndrome; AHA; American heart asso
Keywords: pediatric cardiology; pediatric pulmonary; pulmonary hypertension; BPD; bronchopulmonary dysplasia; CDH; congenital diaphragmatic hernia; FDA; US Food and Drug Administration; NT-proBNP; N-terminal pro-brain-type natriuretic peptide; PAH; pulmonary arteri
Keywords: BP; blood pressure; CAD; coronary artery disease; CHF; congestive heart failure; DM; diabetes mellitus; FBG; fasting blood glucose; HDL-C; high-density lipoprotein cholesterol; HR; hazard ratio; HTN; hypertension; LV; left ventricular; MI; myocardial infa
Keywords: APDS; aminoethylpyridyldisulfide; APS; ammonium persulfate; ASP; apple stem pitting virus; AuNR; gold nanorod; BIS; N,N-methylenebisacrylamide; BSA; bovine serum albumin; BHb; bovine hemoglobin; CD; cyclodextrin; CNT; carbon nanotube; CV; cyclic voltammet
Keywords: ADD; adynamic done disease; AH; arterial hypertension; BMI; body mass index; BP; blood pressure; CAD; coronary artery disease; CKD; chronic kidney disease; CVE; cardiovascular event; DBP; diastolic blood pressure; DM; diabetes mellitus; DN; diabetic nephr
Keywords: CB-CAPs; cell-bound complement activation products; EPCs; endothelial progenitor cells; IRF; interferon regulatory factor; LN; lupus nephritis; NT-proBNP; neurohormone NT-pro brain naturetic protein; piHDL; pro-inflammatory high density lipoprotein; PON3;